Search
BioLine RX Ltd
BLRXAdd to Watchlist
2.800USD
+0.040+1.45%
Market hours （ET）Quotes delayed by 15 min
12.18MMarket Cap
LossP/E TTM
Forecast
Currency: USD Updated: 2026-08-14No earnings forecast score is currently available for BioLine RX Ltd. The Biotechnology & Medical Research industry's average is 8.10. The average price target is 26.00, with a high of 40.00 and a low of 12.00.
Analyst Rating
Based on
0
analysts
--
Current Rating
23.000
Target Price
+733.33%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
497
Total
6
Median
7
Average
Company name
Ratings
Analysts
BioLine RX Ltd
BLRX
0
argenx SE
ARGX
28
Beigene Ltd
ONC
28
Ionis Pharmaceuticals Inc
IONS
25
IQVIA Holdings Inc
IQV
24
Kymera Therapeutics Inc
KYMR
23
1
2
3
...
100
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is BioLine RX Ltd's expected revenue for the next quarter?
BioLine RX Ltd's expected revenue is 477.00K.
What is BioLine RX Ltd's price target?
Analysts forecast that BioLine RX Ltd's price target is USD 26.00, with the highest forecast at USD 40.00 and the lowest forecast at USD 12.00.